Apidemia IVS: Financial statements 2019
CVR: 37503312
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Apidemia IVS (CVR 37503312) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 322,296 and a net result of DKK 59,896 compared with DKK -355,318 the year before. That is an increase of 52.5% compared with the year before. Equity in the 2019 report amounted to DKK -941,029. The company had 1 employee in the financial year.
- Gross Profit
- DKK 322,296
- Profit/Loss
- DKK 59,896
- Equity
- DKK -941,029
- Total Assets
- DKK 372,763
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 322K | 60K | -941K | 1 |
| 2018 | - | 211K | -355K | -1M | 2 |
| 2017 | - | 243K | -384K | -646K | 2 |
| 2016 | - | -105K | -262K | -262K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Apidemia IVS has published its annual report for 2018. Gross profit came to DKK 211,284, and the net result was DKK -355,318.
About Apidemia IVS
Apidemia IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 10 November 2022. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company was previously named dotboost IVS. The company has 2 employees (2021). In 2020, the company reported a gross profit of DKK 161,017 and a net result of DKK -201,443 compared with DKK 59,896 the year before. Equity in the 2020 report amounted to DKK -1,142,472.